Mridula Kadalbajoo

Title: The Innovative Contributions of Mridula Kadalbajoo

Introduction

Mridula Kadalbajoo is a prominent inventor based in Farmingdale, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 3 patents to her name, her work is paving the way for new therapeutic options.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Substituted pteridinones for the treatment of cancer." This patent focuses on compounds of Formula I, which include pharmaceutically acceptable salts, synthesis methods, intermediates, formulations, and treatment methods for diseases, particularly cancers driven or mediated by RSK. Another notable patent is for "Substituted imidazopyr- and imidazotri-azines," which describes fused pyridine-based bicyclic compounds with the structure of Formula I, along with their preparation, compositions, and applications in disease treatment.

Career Highlights

Mridula Kadalbajoo is currently employed at Osi Pharmaceuticals, Inc., where she continues to innovate and contribute to the pharmaceutical industry. Her work is characterized by a commitment to developing effective treatments for serious health conditions.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Mark Joseph Mulvihill and Andrew Philip Crew. These partnerships have enhanced her research and development efforts, leading to impactful advancements in her field.

Conclusion

Mridula Kadalbajoo's contributions to pharmaceutical innovations are noteworthy and reflect her dedication to improving cancer treatment options. Her patents and collaborations highlight her role as a significant figure in the industry.